Congress OKs Prescription Drug User Fee Act

LJP Names New VP Of Clinical Development

BIOTECH
by Marion Webb, Senior Staff Writer

A bill designed to speed the drug-review process by collecting more money from the biotechnology and pharmaceutical industries was approved by Congress with a near-unanimous vote...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129